Esco Group is a research and development oriented international enterprise headquartered in Singapore, dedicated to the fields of life sciences and healthcare, consisting of companies from the United States, Europe, and Asia. The vision of Esco Group is to invent and discover innovative technologies and commercialize them to make human life healthier and safer. Esco Group is a research and development oriented international enterprise headquartered in Singapore, dedicated to the fields of life sciences and healthcare. It has over 30 subsidiaries and more than 1000 employees. Its self operated products and services cover more than 100 countries worldwide. Our business operations include: Esco Lifesciences, Esco Medical, and Esco HealthCare. The Esco Group is privately owned by the Lim family and led by the group's President and CEO, X. Q Lim. Years of management experience and keen business acumen have made President Lin realize the importance of corporate transformation and innovative change, while also firmly grasping the opportunities and directions of industry development. Therefore, since managing the Esco Group, Esco has gradually entered the pharmaceutical equipment and IVF equipment industries. Given the unmet demand in the global healthcare market and the aging population, Esco has established Esco Ventures as the venture capital department of the Esco Group to invest in life science startups worldwide. Comprehensively reform the business scope of Esco Group and continue to expand and refine Esco's business map globally. Implementing Esco Group's business goal of "World Class, Worldwide"! Corporate Culture Esco Vision: To make people's lives healthier and safer through the application of modern technological inventions and innovative technologies. ESCO mission: Adhere to reform and innovation, forge ahead, and meet the different needs of customers· Adhere to the Esco business system strategy and continuously improve operational efficiency· Expand global business scope and increase market share· Improve products, optimize services, and increase sustainability benefits· Establish a leading life science ecosystem and conduct comprehensive business in the fields of life sciences, diagnosis, medical technology, biotechnology, cell and gene therapy, funding, and healthcare services· To become a leading life science enterprise in Southeast Asia, strengthen localization operations in China, Europe, and the United States, and promote factory construction and local team building. Provide employees with growth opportunities and humanistic care. Esco's core values drive various aspects of enterprise growth: attitude, communication, ability, commitment, and growth. Esco Group branches and product overview. Esco Lifesciences is the life science laboratory equipment branch of Esco Group, with main products including biosafety cabinets, carbon dioxide incubators, ultra clean workbenches, centrifuges, ultra-low temperature refrigerators, etc. As a traditional business of Esco Group, it is also the foundation for us to establish a global market access platform. Please refer to www.escolibiosciences. cn for details. ESCO's life science department is dedicated to designing and producing secondary biosafety cabinets, tertiary biosafety cabinets, vertical flow ultra clean workbenches, horizontal flow ultra clean workbenches, laboratory fume hoods/cabinets, laboratory cabinets for other purposes, and other space efficient purification equipment. Our technical background in cleanroom engineering and air purification makes us more competitive than other laboratory equipment suppliers. Biosafety and Cleanliness Products: A2 Biosafety Cabinet, B2 Biosafety Cabinet, Level 3 Biosafety Cabinet, Laboratory Animal Research Safety Cabinet, Horizontal Laminar Flow Ultra Clean Workbench, Vertical Laminar Flow Ultra Clean Workbench, PCR Special Ultra Clean Workbench Ventilation Cabinets: Laboratory Ventilation Cabinets, Ductless Ventilation Cabinets, Incubators and Ovens: Forced Convection Laboratory Oven, Forced Convection Laboratory Incubator, Carbon Dioxide Incubator, Remote Monitoring Data Recording and Program Control Software Gene Amplification Instrument: Gradient Gene Amplification Instrument Low Temperature Storage Products: Vertical Ultra Low Temperature Refrigerator IVF specific multi chamber incubator, IVF specific validation equipment, anti vibration micro operation test bench shaker: laboratory shaker assisted reproductive technology products: ART workstation, oxygen suppressing carbon dioxide culture clean pharmaceutical products: sterile testing isolator, clean laminar flow weighing room, powder sample weighing cabinet, isolated drug operation safety cabinet centrifuge: laboratory desktop micro centrifuge, laboratory desktop universal centrifuge Esco Medical is the medical equipment branch of Esco Group, providing innovative reproductive assistance solutions to all IVF clinics and hospitals. The provided equipment includes IVF specific multi chamber incubators, embryo differential monitoring and optimal fertility systems, multi zone temperature controlled IVF workstations, IVF specific carbon dioxide incubators, and anti vibration test benches. Please refer to www.escommedical.com for details. Esco HealthCare consists of four different brands, providing commercial (usually customized) patented and proprietary manufacturing tools, and utilizing these tools to provide CDMO services. The Esco healthcare department consists of three branches: Pharma, Tapestle Rx, and VacciXcell. Phama focuses on the research and production of sterile drug testing isolators, isolated operation safety cabinets, pharmaceutical clean operation weighing rooms, and other series of products; Tapestle Rx creates a complete laboratory solution for customers; VacciXcell mainly produces and sells biological processing equipment for adherent cell culture. Esco Ventures X is Esco Ventures' entrepreneurial incubation platform system, which transforms cutting-edge innovative inventions and scientific research incubation into life and health startups. Please refer to www.escoveventures.com. Esco Aster is a Contract Research and Production Organization (CDMO) that primarily utilizes its proprietary tidal technology, bioprocessing, and bioengineering equipment to provide development and biomanufacturing services for vaccines, cell and gene therapies. For more information, please visit www.escaster.com. At present, Esco Group's investment portfolio includes Carmentix Triventures II Fund、Hummingbird、Nanoview Diagnostics、AT Medical、Check Cap、Javelin Medical、Medical Plast In addition, Esco is developing innovative diagnostic services. One of our portfolio companies is Carmentix, which has developed a new predictive test for premature birth in asymptomatic women to enable early prevention. Please refer to www.carmentix.com. Esco products are sold and serviced in over 100 countries, with direct sales in certain markets and distribution in others. We have factories in the United States, United Kingdom, Lithuania, Indonesia, and China. There are sales/service companies/offices in the United States, the United Kingdom, Denmark, Italy, Russia, the United Arab Emirates, India (joint venture), South Africa (joint venture), Bangladesh, Malaysia, Thailand, Indonesia, the Philippines, Vietnam, Singapore, Chinese Mainland, Hong Kong, Taiwan and South Korea. Our investment is mainly completed through Esco Ventures. Esco Ventures, as the venture capital division of the Esco Group, invests in life science startups worldwide. We invest in the budding/Series A financing stage, with fund tracking capabilities covering the fields of therapeutics, women's health, and life science tools worldwide. We have also established incubation platforms in Singapore and Beijing. Our Singapore incubation platform Esco Ventures X is a model for our life science venture capital firm, which addresses unmet medical needs based on our own research hypotheses and/or in close collaboration with global academic laboratories. We have established a global network consisting of academic institutions, life science venture capital firms, major global pharmaceutical companies, and clinical/scientific/industry consultants. Our internally established startups include Carmentix, which is developing a predictive biological marker for predicting (and thus preventing) premature birth.